Drosophila melanogaster and its Genetic Tools as a Model in the Neurological Disorder Research

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 32

فایل این مقاله در 30 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJABBR-13-5_005

تاریخ نمایه سازی: 21 آبان 1405

چکیده مقاله:

Fruit flies known scientifically as Drosophila melanogaster provide essential research benefits for understanding human neurological disorders through their human-like genetics and highly developed genetic research capabilities. Scientists use Drosophila as an efficient disease mechanism study because approximately ۷۵% of human disease-related genes possess counterparts in Drosophila. The GAL۴/UAS system enables researchers to control which tissues and specific time periods activate gene expression and forward and reverse genetic approaches help identify genes that contribute to neurodegeneration along with their functional assessment. The modifier screen methodology allows scientists to find genes which either increase or reduce disease manifestation. These research tools alongside the well-understanding of Drosophila nervous system and short life span make this organism optimal for simulating diseases including Alzheimer's along with Parkinson's and Huntington's disease and amyotrophic lateral sclerosis (ALS). Through Drosophila research models scientists study how proteins aggregate as well as synaptic breakdown and oxidative damage which are common abnormalities in neurodegenerative disorders. Behavioural tests combined with tissue analysis techniques together with automated drug screening help scientists advance disease research and therapeutic discovery. The structural dissimilarities between flying insects and humans fail to diminish Drosophila's usefulness for studying neurological processes in human disease investigations. The review presented insights about genetic research and laboratory applications of D. melanogaster to study neurological diseases and develop intervention strategies.

نویسندگان

- -

Department of Drug Discovery and Development, University of Lagos, Lagos, Nigeria

- -

Department of Human Physiology, Basic Medical Sciences, Chukwuemeka Odumegwu Ojukwu University Anambra, Nigeria

- -

Department of Medical Rehabilitation/Physiotherapy, Health Sciences and Technology, University of Nigeria, Nsukka, Nigeria

- -

Department of Biological Sciences, University of Camerino, Italy

- -

Department of Medicine and Surgery, College of Medicine, University of Ibadan, Nigeria

- -

Department of Medicine and Surgery, College of Medicine, University of Lagos, Lagos, Nigeria

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :